| |
|
Pharmacokinetics of Sifuvirtide in Treatment-Naive and
Treatment-Experienced HIV-Infected Patients.
Meng Q, Dong T, Chen X, et al
J Pharm Sci. 2014 Oct 7
Abstract
The M-T hook structure increases the potency of
HIV-1 fusion inhibitor sifuvirtide and overcomes drug resistance.
Chong H, Yao X, Qiu Z, et al
J Antimicrob Chemother. 2014
Oct;69(10):2759-69
Abstract
FULL-TEXT ARTICLE
Efficacy, Stability, and Biosafety of Sifuvirtide Gel as a Microbicide Candidate
against HIV-1.
Li L, Ben Y, Yuan S, et al
PLoS One.
2012;7(5):e37381.
Paper
FULL-TEXT ARTICLE
In
vitro selection and characterization of HIV-1 variants with increased resistance
to sifuvirtide,
a
novel HIV-1 fusion inhibitor.
Liu Z, Shan M, Li L,
J Biol Chem. 2011 Feb 4;286(5):3277-87
Paper |
Broad antiviral activity and crystal structure of HIV-1 fusion
inhibitor Sifuvirtide.
Yao X, Chong H, Zhang C
J Biol Chem. 2012 Jan 6.
Abstract
In vitro selection and characterization of HIV-1 variants with
increased resistance to sifuvirtide,
novel HIV-1 fusion inhibitor.
Liu Z, Shan M, Li L,
et al
J Biol Chem. 2011 Feb 4;286(5):3277-87.
Abstract
|
Quantitative analysis of a novel HIV fusion inhibitor (sifuvirtide) in HIV
infected human
plasma using high-performance liquid chromatography-electrospray ionization
tandem
mass spectrometry.
Che J, Meng Q, Chen Z, et al
J Pharm Biomed Anal.
2009 Oct 30.
Abstract |
Sifuvirtide, a potent HIV fusion inhibitor peptide.
Wang RR, Yang LM, Wang YH, et al
Biochem Biophys Res Commun. 2009 Mar 13
Abstract |
Synergistic efficacy of combination of enfuvirtide and sifuvirtide,
the first- and next-generation
HIV-fusion inhibitors.
Pan C, Lu H, Qi Z, Jiang S.
AIDS. 2009 Feb 24
|
Design and evaluation of sifuvirtide: a novel HIV-1 fusion
inhibitor.
He Y, Xiao Y, Song H, et al
J Biol Chem. 2008 Feb 26
Abstract |
New
and Noteworthy
ARV Investigational Drugs 
Documents
identified with this icon are in Portable Document Format (PDF) and require the
Adobe
Acrobat Reader